Trial intelligence / Profile preview

Offspring Development Safety of Prenatal Telbivudine Exposure

ChiCTR-OPC-16009018Phase 4Completed

Sponsor
Key Laboratory of Reproductive Genetics
Start
Jan 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of telbivudine in Chronic Hepatitis B (CHB) (3 arms), sponsored by Key Laboratory of Reproductive Genetics. Started Jan 2012; status: completed.

02

Drugs

telbivudine
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on ChiCTR-OPC-16009018.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OPC-16009018.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call